DK27383A - Fremgangsmaade til fremstilling af pyrazol(4,3-c)pyridiner - Google Patents

Fremgangsmaade til fremstilling af pyrazol(4,3-c)pyridiner Download PDF

Info

Publication number
DK27383A
DK27383A DK27383A DK27383A DK27383A DK 27383 A DK27383 A DK 27383A DK 27383 A DK27383 A DK 27383A DK 27383 A DK27383 A DK 27383A DK 27383 A DK27383 A DK 27383A
Authority
DK
Denmark
Prior art keywords
pyridines
procedure
preparing pyrazole
pyrazole
preparing
Prior art date
Application number
DK27383A
Other languages
Danish (da)
English (en)
Other versions
DK27383D0 (da
Inventor
Giorgio Winters
Alberto Sala
Domenico Barone
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of DK27383D0 publication Critical patent/DK27383D0/da
Publication of DK27383A publication Critical patent/DK27383A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK27383A 1982-02-17 1983-01-25 Fremgangsmaade til fremstilling af pyrazol(4,3-c)pyridiner DK27383A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8204722 1982-02-17

Publications (2)

Publication Number Publication Date
DK27383D0 DK27383D0 (da) 1983-01-25
DK27383A true DK27383A (da) 1983-08-18

Family

ID=10528419

Family Applications (1)

Application Number Title Priority Date Filing Date
DK27383A DK27383A (da) 1982-02-17 1983-01-25 Fremgangsmaade til fremstilling af pyrazol(4,3-c)pyridiner

Country Status (16)

Country Link
US (1) US4500525A (zh)
EP (1) EP0086422B1 (zh)
JP (1) JPS58152885A (zh)
KR (1) KR900006853B1 (zh)
AT (1) ATE30027T1 (zh)
AU (1) AU563591B2 (zh)
CA (1) CA1225646A (zh)
DE (1) DE3373904D1 (zh)
DK (1) DK27383A (zh)
ES (3) ES8500273A1 (zh)
GR (1) GR78080B (zh)
IE (1) IE55156B1 (zh)
IL (1) IL67785A0 (zh)
NZ (1) NZ203302A (zh)
PH (1) PH23645A (zh)
ZA (1) ZA83628B (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137890A (en) * 1990-02-14 1992-08-11 Ortho Pharmaceutical Corporation 4-phenyl tetrahydropyrido(4,3-d)pyrimidines
US5264576A (en) * 1992-10-22 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Pyrazolo[4,3-c]pyridines which are intermediates
DE19834044A1 (de) * 1998-07-29 2000-02-03 Bayer Ag Neue substituierte Pyrazolderivate
US20070117785A1 (en) * 2000-08-14 2007-05-24 Butler Christopher R Substituted pyrazoles and methods of treatment with substituted pyrazoles
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
US20070105841A1 (en) * 2000-08-14 2007-05-10 Breitenbucher J G Method for treating allergies using substituted pyrazoles
MXPA03001422A (es) 2000-08-14 2004-01-26 Johnson & Johnson Pirazoles substituidos.
MXPA03001420A (es) * 2000-08-14 2004-01-26 Johnson & Johnson Pirazoles sustituidos.
US20050101587A9 (en) * 2000-08-14 2005-05-12 Butler Christopher R. Method for treating allergies using substituted pyrazoles
AU8125501A (en) * 2000-08-14 2002-02-25 Ortho Mcneil Pharm Inc Substituted pyrazoles
MXPA03001964A (es) * 2000-09-06 2004-03-26 Johnson & Johnson Metodo para el tratamiento de alergias usando pirazoles substituidos.
AU2001288714A1 (en) 2000-09-06 2002-03-22 Ortho-Mcneil Pharmaceutical, Inc. A method for treating allergies
AU2003231880A1 (en) * 2002-05-30 2003-12-19 Vertex Pharmaceuticals Incorporated Inhibitors of jak and cdk2 protein kinases
AU2003244632A1 (en) * 2002-07-25 2004-02-25 Pharmacia Italia S.P.A. Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
EP2243781A1 (en) * 2003-05-30 2010-10-27 Vertex Pharmaceuticals, Inc. Pyrazolopyridine derivatives as inhibitors of JAK and CDK2 protein kinases
CN103788089A (zh) 2003-09-17 2014-05-14 詹森药业有限公司 作为血清素受体调节剂的稠合杂环化合物
US7652135B2 (en) 2003-09-23 2010-01-26 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
KR100838692B1 (ko) 2007-07-11 2008-06-16 한국화학연구원 7-(3′,4′-디알콕시페닐)-4,5,6,7-테트라히드로피라졸로[1,5-ａ]피리미딘 화합물, 이의 제조방법 및 이를 포함하는천식 및 만성폐쇄성 폐질환을 포함한 염증관련 질환,관절염, 아토피 피부염, 암 및 뇌질환의 치료 및 예방을위한 약제학적 조성물
EP2615916B1 (en) * 2010-09-16 2017-01-04 Merck Sharp & Dohme Corp. Fused pyrazole derivatives as novel erk inhibitors
EA023648B1 (ru) * 2011-09-12 2016-06-30 Санофи ИНДАНИЛЗАМЕЩЕННЫЕ 4,5,6,7-ТЕТРАГИДРО-1H-ПИРАЗОЛО[4,3-с]ПИРИДИНЫ, ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННОГО СРЕДСТВА И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ
SI2755972T1 (sl) 2011-09-12 2016-02-29 Sanofi Indanil-substituirani 4,5,6,7-tetrahidro-1H-pirazolo(4,3-c)piridini, njihova uporaba kot zdravilo in farmacevtski pripravki, ki jih vsebujejo
WO2013037415A1 (en) * 2011-09-16 2013-03-21 Sanofi Substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them
WO2013037914A1 (en) 2011-09-16 2013-03-21 Sanofi Substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them
US9518057B2 (en) * 2014-12-30 2016-12-13 Novira Therapeutics, Inc. Derivatives and methods of treating hepatitis B infections
JP7014736B2 (ja) * 2016-05-24 2022-02-01 ジェネンテック， インコーポレイテッド がんの処置のためのピラゾロピリジン誘導体
WO2018005881A1 (en) 2016-06-29 2018-01-04 Novira Therapeutics, Inc. Oxadiazepinone derivatives and their use in the treatment of hepatitis b infections
JP6935433B2 (ja) 2016-06-29 2021-09-15 ノヴィラ・セラピューティクス・インコーポレイテッド ジアゼピノン誘導体及びｂ型肝炎感染症の治療におけるその使用
CN110997674B (zh) 2017-05-31 2022-12-20 凯莫森特里克斯股份有限公司 作为C5a抑制剂的6-5稠合环类
CN111788185A (zh) * 2017-12-22 2020-10-16 凯莫森特里克斯股份有限公司 作为C5a抑制剂的二芳基取代的6,5稠合环化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852279A (en) * 1973-03-12 1974-12-03 Squibb & Sons Inc 7-substituted -3,3a,4,5,6,7-hexahydro-3-substituted-2h- pyrazolo (4,3-c)pyridines

Also Published As

Publication number Publication date
JPS58152885A (ja) 1983-09-10
ES519832A0 (es) 1984-10-01
ES531980A0 (es) 1985-09-01
EP0086422A3 (en) 1984-03-28
CA1225646A (en) 1987-08-18
IL67785A0 (en) 1983-05-15
ES531981A0 (es) 1985-09-01
KR900006853B1 (ko) 1990-09-22
DK27383D0 (da) 1983-01-25
DE3373904D1 (en) 1987-11-05
US4500525A (en) 1985-02-19
IE830328L (en) 1983-08-17
EP0086422B1 (en) 1987-09-30
AU563591B2 (en) 1987-07-16
AU1130583A (en) 1983-08-25
NZ203302A (en) 1986-08-08
GR78080B (zh) 1984-09-26
ZA83628B (en) 1983-12-28
IE55156B1 (en) 1990-06-20
PH23645A (en) 1989-09-27
JPH0412269B2 (zh) 1992-03-04
ES8507547A1 (es) 1985-09-01
KR840003636A (ko) 1984-09-15
ES8500273A1 (es) 1984-10-01
EP0086422A2 (en) 1983-08-24
ES8507546A1 (es) 1985-09-01
ATE30027T1 (de) 1987-10-15

Similar Documents

Publication Publication Date Title
DK27383A (da) Fremgangsmaade til fremstilling af pyrazol(4,3-c)pyridiner
IL72120A (en) 2-pyrimidinyl-1-piperazine derivatives,their preparation and pharmaceutical compositions containing them
ES8700240A1 (es) Procedimiento para preparar nuevos derivados de benzazocino-na y de benzaconinona
ES8400076A1 (es) Procedimiento para hidroformilar compuestos olefinicamente insaturados.
ES8200094A1 (es) Procedimiento para la obtencion de alquilureas
ES8305783A1 (es) Procedimiento para la obtencion de derivados de aminociclitol saturados.
ES8200871A1 (es) Procedimiento para la obtencion de derivados de 2-amino-3,4-dihidropiridina
ES474575A1 (es) Procedimiento de producir (omega-aminoalcoxi)bibencilos far-maceuticamente activos

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment